Evidence map›Paper›PMID 28595647›Full record

ArticleBreast cancer research : BCR2017

Pubertal development in girls by breast cancer family history: the LEGACY girls cohort.

Mary Beth Terry, Theresa H M Keegan, Lauren C Houghton, Mandy Goldberg, Irene L Andrulis, Mary B Daly, Saundra S Buys, Ying Wei, Alice S Whittemore, Angeline Protacio and 4 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Observational
  3. Improvement on recovery and reproducibility for quantifying urinary mono-hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs).Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Mary Beth TerryDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY, 10032, USA. mt146@cumc.columbia.edu.
Theresa H M KeeganDivision of Hematology and Oncology, University of California (UC) Davis School of Medicine, and UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Lauren C HoughtonDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY, 10032, USA.
Mandy GoldbergDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY, 10032, USA.
Irene L AndrulisDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Mary B DalyDepartment of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
Saundra S BuysDepartment of Medicine, University of Utah Health Sciences Center, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Ying WeiDepartment of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.
Alice S WhittemoreDepartments of Biomedical Data Sciences and Health Research and Policy, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Angeline ProtacioDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY, 10032, USA.
Angela R BradburyDepartments of Medicine, Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wendy K ChungHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
Julia A KnightLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Esther M JohnCancer Prevention Institute of California, Fremont, CA, USA.
Columbia University · USStanford University · USColumbia University Irving Medical Center · USFox Chase Cancer Center · USSinai Health System · CAUC Davis Comprehensive Cancer CenterUniversity of Pennsylvania · USUniversity of Toronto · CAUniversity of Utah · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Pregnancy and Prenatal PAHs and other Environmental Exposures and Breast CancerU01ES026122 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MILLER, RACHEL L, TERRY, MARY BETH · 2015 to 2019
$4.5M
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family RegistryR01CA138638 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI JOHN, ESTHER M. · 2011 to 2015
$3.6M
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family RegistryR01CA138819 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI BRADBURY, ANGELA R., DALY, MARY BERYL · 2011 to 2015
$3.3M
LEGACY: A cohort of youth in families from the Breast Cancer Family RegistryR01CA138822 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TERRY, MARY BETH · 2011 to 2015
$3.0M
LEGACY: A cohort of youth in families from the Breast Cancer Family RegistryR01CA138844 · NCI · SINAI HEALTH SYSTEM · PI ANDRULIS, IRENE · 2011 to 2015
$1.8M
NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA138638NCI NIH HHS R01 CA138819NCI NIH HHS R01 CA138822NCI NIH HHS R01 CA138844NIEHS NIH HHS U01 ES026122
6 · The paper itself

Abstract

backgroundPubertal milestones, such as onset of breast development and menstruation, play an important role in breast cancer etiology. It is unclear if these milestones are different in girls with a first- or second-degree breast cancer family history (BCFH).

methodsIn the LEGACY Girls Study (n = 1040), we examined whether three mother/guardian-reported pubertal milestones (having reached Tanner Stage 2 or higher (T2+) for breast and pubic hair development, and having started menstruation) differed by BCFH. We also examined whether associations between body size and race/ethnicity and pubertal milestones were modified by BCFH. We used mother/guardian reports as the primary measure of pubertal milestones, but also conducted sensitivity analyses using clinical Tanner measurements available for a subcohort (n = 204). We analyzed cross-sectional baseline data with logistic regression models for the entire cohort, and longitudinal data with Weibull survival models for the subcohort of girls that were aged 5-7 years at baseline (n = 258).

resultsBCFH was modestly, but not statistically significantly, associated with Breast T2+ (odds ratio (OR) = 1.36, 95% confidence interval (CI) = 0.88-2.10), with a stronger association seen in the subcohort of girls with clinical breast Tanner staging (OR = 2.20, 95% CI = 0.91-5.32). In a longitudinal analysis of girls who were aged 5-7 years at baseline, BCFH was associated with a 50% increased rate of having early breast development (hazard ratio (HR) = 1.49, 95% CI = 1.0-2.21). This association increased to twofold in girls who were not overweight at baseline (HR = 2.04, 95% CI = 1.29-3.21). BCFH was not associated with pubic hair development and post-menarche status. The median interval between onset of breast development and menarche was longer for BCFH+ than BCFH- girls (2.3 versus 1.7 years), suggesting a slower developmental tempo for BCFH+ girls. Associations between pubertal milestones and body size and race/ethnicity were similar in girls with or without a BCFH. For example, weight was positively associated with Breast T2+ in both girls with (OR = 1.06 per 1 kg, 95% CI = 1.03-1.10) and without (OR = 1.14 per 1 kg, 95% CI = 1.04-1.24) a BCFH.

conclusionsThese results suggest that BCFH may be related to earlier breast development and slower pubertal tempo independent of body size and race/ethnicity.

Indexed as

PubertyBody Mass IndexBreast NeoplasmsCanadaChildChild, PreschoolCohort StudiesFemaleHumansIncidenceKaplan-Meier EstimateMenarcheOdds RatioPopulation SurveillanceRiskUnited StatesBMIBreast cancerBreast cancer family historyMenarchePubertal development

Identifiers

PMID28595647
PMCPMC5465536
OpenAlexW2623940194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.